Very weird appointments. How on earth can these two advance CVTs prospects. I continue to sit on the side lines and wait for something more (much more) constructive before buying back in.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025